brain disease News
Most Popular brain disease Story
Novartis joins exodus from traditional R&D neuroscience drug work
Novartis ($NVS) is joining the global exodus from the field of traditional drug research for brain disorders. Nature reports that the pharma giant has set in motion plans to shut down its Read more...
Latest Headlines
- June 28, 2006
- June 5, 2006
- April 27, 2006
- March 9, 2006
- March 8, 2006
- March 6, 2006
- February 15, 2006
- September 26, 2005
- August 8, 2005
- June 29, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
